Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Microbiological profile of ozenoxacin.

Morrissey I, Cantón R, Vila J, Gargallo-Viola D, Zsolt I, Garcia-Castillo M, López Y.

Future Microbiol. 2019 Jun;14:773-787. doi: 10.2217/fmb-2019-0089. Epub 2019 May 28.

2.

In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from U.S. and European Hospitals during 2014-2015.

Morrissey I, Magnet S, Hawser S, Shapiro S, Knechtle P.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00514-19. doi: 10.1128/AAC.00514-19. Print 2019 Jul.

3.

Survey of antimicrobial susceptibility of bacterial pathogens isolated from dogs and cats with respiratory tract infections in Europe: ComPath results.

Moyaert H, de Jong A, Simjee S, Rose M, Youala M, El Garch F, Vila T, Klein U, Rzewuska M, Morrissey I.

J Appl Microbiol. 2019 Jul;127(1):29-46. doi: 10.1111/jam.14274. Epub 2019 May 16.

PMID:
30955231
4.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.

Torumkuney D, Nica M, Nistor I, Vatcheva-Dobrevska R, Petrovic V, Stoica A, Hanicar B, Antic D, Morrissey I.

J Antimicrob Chemother. 2018 Aug 1;73(8):2275. doi: 10.1093/jac/dky219. No abstract available.

PMID:
29901783
5.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.

Torumkuney D, Pertseva T, Bratus E, Dziublik A, Yachnyk V, Liskova A, Sopko O, Malynovska K, Morrissey I.

J Antimicrob Chemother. 2018 Aug 1;73(8):2276. doi: 10.1093/jac/dky220. No abstract available.

PMID:
29901766
6.

Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.

Canton R, Morrissey I, Vila J, Tato M, García-Castillo M, López Y, Gargallo-Viola D, Zsolt I.

Future Microbiol. 2018 May 1;13:3-19. doi: 10.2217/fmb-2017-0289.

7.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic.

Torumkuney D, Pertseva T, Bratus E, Dziublik A, Yachnyk V, Liskova A, Sopko O, Malynovska K, Morrissey I.

J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v28-v35. doi: 10.1093/jac/dky069.

PMID:
29659885
8.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Greece.

Torumkuney D, Papaparaskevas J, Morrissey I.

J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v36-v42. doi: 10.1093/jac/dky068.

PMID:
29659884
9.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic.

Torumkuney D, Zemlickova H, Maruscak M, Morrissey I.

J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v22-v27. doi: 10.1093/jac/dky067.

PMID:
29659883
10.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia.

Torumkuney D, Nica M, Nistor I, Vatcheva-Dobrevska R, Petrovic V, Stoica A, Hanicar B, Antic D, Morrissey I.

J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v2-v13. doi: 10.1093/jac/dky066.

PMID:
29659882
11.

Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia.

Torumkuney D, Mayanskiy N, Edelstein M, Sidorenko S, Kozhevin R, Morrissey I.

J Antimicrob Chemother. 2018 Apr 1;73(suppl_5):v14-v21. doi: 10.1093/jac/dky065.

PMID:
29659881
12.

Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.

Everett M, Sprynski N, Coelho A, Castandet J, Bayet M, Bougnon J, Lozano C, Davies DT, Leiris S, Zalacain M, Morrissey I, Magnet S, Holden K, Warn P, De Luca F, Docquier JD, Lemonnier M.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e00074-18. doi: 10.1128/AAC.00074-18. Print 2018 May.

13.

Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.

Huang DB, Morrissey I, Murphy T, Hawser S, Wilcox MH.

Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):673-678. doi: 10.1007/s10096-017-3159-5. Epub 2017 Dec 8.

14.

Surveillance of the activity of solithromycin (CEM-101) against bacteria from respiratory tract infections.

Hawser S, Morrissey I, Lemos B, Keedy K, Fernandes P.

Int J Antimicrob Agents. 2017 Jul;50(1):17-22. doi: 10.1016/j.ijantimicag.2017.01.035. Epub 2017 May 5.

PMID:
28483717
15.

Antimicrobial Susceptibility Monitoring of Bacterial Pathogens Isolated from Urinary Tract Infections in Dogs and Cats Across Europe: ComPath Results.

Moyaert H, Morrissey I, de Jong A, El Garch F, Klein U, Ludwig C, Thiry J, Youala M.

Microb Drug Resist. 2017 Apr;23(3):391-403. doi: 10.1089/mdr.2016.0110. Epub 2016 Oct 19.

PMID:
28384093
16.

Survey of susceptibility to marbofloxacin in bacteria isolated from diseased pigs in Europe.

El Garch F, Kroemer S, Galland D, Morrissey I, Woehrle F.

Vet Rec. 2017 Jun 17;180(24):591. doi: 10.1136/vr.103954. Epub 2017 Mar 27.

PMID:
28348142
17.

Antimicrobial susceptibility monitoring of dermatological bacterial pathogens isolated from diseased dogs and cats across Europe (ComPath results).

Ludwig C, de Jong A, Moyaert H, El Garch F, Janes R, Klein U, Morrissey I, Thiry J, Youala M.

J Appl Microbiol. 2016 Nov;121(5):1254-1267. doi: 10.1111/jam.13287.

PMID:
27593360
18.

Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.

Torumkuney D, Chaiwarith R, Reechaipichitkul W, Malatham K, Chareonphaibul V, Rodrigues C, Chitkins DS, Dias M, Anandan S, Kanakapura S, Park YJ, Lee K, Lee H, Kim JY, Lee Y, Lee HK, Kim JH, Tan TY, Heng YX, Mukherjee P, Morrissey I.

J Antimicrob Chemother. 2016 Dec;71(12):3628. Epub 2016 Aug 23. No abstract available.

PMID:
27559118
19.

Dissemination of Novel Antimicrobial Resistance Mechanisms through the Insertion Sequence Mediated Spread of Metabolic Genes.

Furi L, Haigh R, Al Jabri ZJ, Morrissey I, Ou HY, León-Sampedro R, Martinez JL, Coque TM, Oggioni MR.

Front Microbiol. 2016 Jun 28;7:1008. doi: 10.3389/fmicb.2016.01008. eCollection 2016.

20.

Antimicrobial susceptibility monitoring of bacterial pathogens isolated from respiratory tract infections in dogs and cats across Europe: ComPath results.

Morrissey I, Moyaert H, de Jong A, El Garch F, Klein U, Ludwig C, Thiry J, Youala M.

Vet Microbiol. 2016 Aug 15;191:44-51. doi: 10.1016/j.vetmic.2016.05.020. Epub 2016 Jun 1.

PMID:
27374906
21.

Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 in Vietnam.

Van PH, Binh PT, Minh NH, Morrissey I, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i93-102. doi: 10.1093/jac/dkw069.

22.

Results from the Survey of Antibiotic Resistance (SOAR) 2002-09 in Turkey.

Torumkuney D, Gur D, Soyletir G, Gurler N, Aktas Z, Sener B, Tunger A, Bayramoglu G, Koksal I, Yalcin AN, Tanriver Y, Morrissey I, Barker K.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i85-91. doi: 10.1093/jac/dkw067.

23.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Turkey.

Soyletir G, Altinkanat G, Gur D, Altun B, Tunger A, Aydemir S, Kayacan C, Aktas Z, Gunaydin M, Karadag A, Gorur H, Morrissey I, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i71-83. doi: 10.1093/jac/dkw075.

24.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in Ukraine.

Feshchenko Y, Dzyublik A, Pertseva T, Bratus E, Dzyublik Y, Gladka G, Morrissey I, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i63-9. doi: 10.1093/jac/dkw068.

25.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-13 in the Gulf States.

Jamsheer A, Rafay AM, Daoud Z, Morrissey I, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i45-61. doi: 10.1093/jac/dkw064.

26.

Results from the Survey of Antibiotic Resistance (SOAR) 2009-11 and 2013-14 in China.

Hu F, Zhu D, Wang F, Morrissey I, Wang J, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i33-43. doi: 10.1093/jac/dkw065.

27.

Results from the Survey of Antibiotic Resistance (SOAR) 2012-14 in Thailand, India, South Korea and Singapore.

Torumkuney D, Chaiwarith R, Reechaipichitkul W, Malatham K, Chareonphaibul V, Rodrigues C, Chitins DS, Dias M, Anandan S, Kanakapura S, Park YJ, Lee K, Lee H, Kim JY, Lee Y, Lee HK, Kim JH, Tan TY, Heng YX, Mukherjee P, Morrissey I.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i3-19. doi: 10.1093/jac/dkw073. Erratum in: J Antimicrob Chemother. 2016 Dec;71(12 ):3628.

28.

Results from the Survey of Antibiotic Resistance (SOAR) 2011-14 in the Democratic Republic of Congo, Ivory Coast, Republic of Senegal and Kenya.

Kacou-Ndouba A, Revathi G, Mwathi P, Seck A, Diop A, Kabedi-Bajani MJ, Mwiti W, Anguibi-Pokou MJ, Morrissey I, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i21-31. doi: 10.1093/jac/dkw070.

29.

Antibiotic susceptibility in Streptococcus pneumoniae, Haemophilus influenzae and Streptococcus pyogenes in Pakistan: a review of results from the Survey of Antibiotic Resistance (SOAR) 2002-15.

Zafar A, Hasan R, Nizamuddin S, Mahmood N, Mukhtar S, Ali F, Morrissey I, Barker K, Torumkuney D.

J Antimicrob Chemother. 2016 May;71 Suppl 1:i103-9. doi: 10.1093/jac/dkw076.

30.

Integrative Advanced Oxidation and Biofiltration for Treating Pharmaceuticals in Wastewater.

Lester Y, Aga DS, Love NG, Singh RR, Morrissey I, Linden KG.

Water Environ Res. 2016 Nov 1;88(11):1985-1993. doi: 10.2175/106143016X14504669767454. Epub 2016 Jan 4.

PMID:
26754427
31.

Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.

Sanfilippo CM, Morrissey I, Janes R, Morris TW.

Curr Eye Res. 2016 May;41(5):581-9. doi: 10.3109/02713683.2015.1045084. Epub 2015 Jul 22.

PMID:
26200173
32.

Activity of RX-P873, a novel pyrrolocytosine, against Gram-negative bacteria.

Morrissey I, Magnet S, Genet E, Jeandey P, Marra A, Hawser S, Duffy E.

Int J Antimicrob Agents. 2015 Sep;46(3):352-4. doi: 10.1016/j.ijantimicag.2015.06.001. Epub 2015 Jun 19. No abstract available.

PMID:
26159867
33.

Antimicrobial susceptibility monitoring of mastitis pathogens isolated from acute cases of clinical mastitis in dairy cows across Europe: VetPath results.

Thomas V, de Jong A, Moyaert H, Simjee S, El Garch F, Morrissey I, Marion H, Vallé M.

Int J Antimicrob Agents. 2015 Jul;46(1):13-20. doi: 10.1016/j.ijantimicag.2015.03.013. Epub 2015 May 4.

PMID:
26003836
34.

Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.

Grandgirard D, Furi L, Ciusa ML, Baldassarri L, Knight DR, Morrissey I, Largiadèr CR, Leib SL, Oggioni MR.

BMC Genomics. 2015 Apr 30;16:345. doi: 10.1186/s12864-015-1544-y.

35.

Significant Differences Characterise the Correlation Coefficients between Biocide and Antibiotic Susceptibility Profiles in Staphylococcus aureus.

Oggioni MR, Coelho JR, Furi L, Knight DR, Viti C, Orefici G, Martinez JL, Freitas AT, Coque TM, Morrissey I; BIOHYPO consortium.

Curr Pharm Des. 2015;21(16):2054-7.

36.

Novel insight into antimicrobial resistance and sensitivity phenotypes associated to qac and norA genotypes in Staphylococcus aureus.

Marchi E, Furi L, Arioli S, Morrissey I, Di Lorenzo V, Mora D, Giovannetti L, Oggioni MR, Viti C.

Microbiol Res. 2015 Jan;170:184-94. doi: 10.1016/j.micres.2014.07.001. Epub 2014 Jul 11.

37.

Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: the VetPath study.

de Jong A, Thomas V, Simjee S, Moyaert H, El Garch F, Maher K, Morrissey I, Butty P, Klein U, Marion H, Rigaut D, Vallé M.

Vet Microbiol. 2014 Aug 6;172(1-2):202-15. doi: 10.1016/j.vetmic.2014.04.008. Epub 2014 Apr 21.

PMID:
24837878
38.

Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.

Hawser S, Hoban DJ, Badal RE, Bouchillon SK, Biedenbach D, Hackel M, Morrissey I.

J Chemother. 2015 Feb;27(2):67-73. doi: 10.1179/1973947814Y.0000000164. Epub 2014 Feb 18.

PMID:
24548089
39.

Evaluation of the Clinical and Laboratory Standards Institute phenotypic confirmatory test to detect the presence of extended-spectrum β-lactamases from 4005 Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae and Proteus mirabilis isolates.

Morrissey I, Bouchillon SK, Hackel M, Biedenbach DJ, Hawser S, Hoban D, Badal RE.

J Med Microbiol. 2014 Apr;63(Pt 4):556-61. doi: 10.1099/jmm.0.068981-0. Epub 2014 Jan 29.

PMID:
24478449
40.

Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms.

Morrissey I, Oggioni MR, Knight D, Curiao T, Coque T, Kalkanci A, Martinez JL; BIOHYPO Consortium.

PLoS One. 2014 Jan 23;9(1):e86669. doi: 10.1371/journal.pone.0086669. eCollection 2014.

41.

A Review of Ten Years of the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2002 to 2011.

Morrissey I, Hackel M, Badal R, Bouchillon S, Hawser S, Biedenbach D.

Pharmaceuticals (Basel). 2013 Nov 1;6(11):1335-46. doi: 10.3390/ph6111335.

42.

Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus.

Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L, Visa P, Northwood JB, Viti C, Borghi E, Orefici G; BIOHYPO Consortium, Morrissey I, Oggioni MR.

Antimicrob Agents Chemother. 2013 Aug;57(8):3488-97. doi: 10.1128/AAC.00498-13. Epub 2013 May 13.

43.

The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus.

Coelho JR, Carriço JA, Knight D, Martínez JL, Morrissey I, Oggioni MR, Freitas AT.

PLoS One. 2013;8(2):e55582. doi: 10.1371/journal.pone.0055582. Epub 2013 Feb 19.

44.

Lack of evidence for reduced fitness of clinical Staphylococcus aureus isolates with reduced susceptibility to triclosan.

Oggioni MR, Ciusa ML, Furi L, Baldassarri L, Orefici G, Cirasola D, Martinez JL, Morrissey I, Borghi E.

Antimicrob Agents Chemother. 2012 Nov;56(11):6068-9; author reply 6072. doi: 10.1128/AAC.01055-12. No abstract available.

45.

Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.

Morrissey I, Seifert H, Canton R, Nordmann P, Stefani S, Macgowan A, Janes R, Knight D; Oritavancin Study Group.

J Antimicrob Chemother. 2013 Jan;68(1):164-7. doi: 10.1093/jac/dks344. Epub 2012 Aug 30.

46.

In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009.

Morrissey I, Leakey A, Northwood JB.

Int J Antimicrob Agents. 2012 Sep;40(3):227-34. doi: 10.1016/j.ijantimicag.2012.05.014. Epub 2012 Jul 15.

PMID:
22796201
47.

A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.

Ciusa ML, Furi L, Knight D, Decorosi F, Fondi M, Raggi C, Coelho JR, Aragones L, Moce L, Visa P, Freitas AT, Baldassarri L, Fani R, Viti C, Orefici G, Martinez JL, Morrissey I, Oggioni MR; BIOHYPO Consortium.

Int J Antimicrob Agents. 2012 Sep;40(3):210-20. Epub 2012 Jul 11.

48.

Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).

Morrissey I, Leakey A.

J Antimicrob Chemother. 2012 Jun;67(6):1408-12. doi: 10.1093/jac/dks038. Epub 2012 Feb 22.

PMID:
22357801
49.

Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.

Valenza G, Seifert H, Decker-Burgard S, Laeuffer J, Morrissey I, Mutters R; COMPACT Germany Study Group.

Int J Antimicrob Agents. 2012 Mar;39(3):255-8. doi: 10.1016/j.ijantimicag.2011.10.015. Epub 2012 Jan 9.

PMID:
22230334
50.

The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.

Escaich S, Prouvensier L, Saccomani M, Durant L, Oxoby M, Gerusz V, Moreau F, Vongsouthi V, Maher K, Morrissey I, Soulama-Mouze C.

Antimicrob Agents Chemother. 2011 Oct;55(10):4692-7. doi: 10.1128/AAC.01248-10. Epub 2011 Aug 8.

Supplemental Content

Loading ...
Support Center